TGTX - CIK 0001001316
The table below shows TG THERAPEUTICS, INC.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $79.15M | $179.89M | $92.93M | $102.30M | $298.89M | $553.44M |
| Short-term investments | $62.82M | $131.11M | $124.58M | $59.37M | $15.88M | $51.99M |
| Receivables | $305.63M | $129.19M | $51.09M | - | - | - |
| Inventory | $125.59M | $110.46M | $39.82M | - | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $630.76M |
| $566.36M |
| $317.94M |
| $168.27M |
| $330.96M |
| $611.74M |
| Property, plant & equipment | - | - | $95.00K | $307.00K | $600.00K | $481.00K |
| Goodwill | - | - | $799.00K | $799.00K | $799.00K | $799.00K |
| Total assets | $1.06B | $577.69M | $329.59M | $193.57M | $379.63M | $625.64M |
| Accounts payable | - | - | - | - | - | - |
| Total current liabilities | $153.76M | $90.68M | $53.72M | $53.20M | $65.38M | $87.55M |
| Long-term debt | $245.65M | $244.43M | $100.12M | $71.14M | $66.79M | $7.72M |
| Total liabilities | $415.23M | $355.33M | $169.09M | $134.99M | $142.48M | $106.29M |
| Retained earnings | -$1.08B | -$1.53B | -$1.51B | -$1.53B | -$1.33B | -$980.60M |
| Total equity | $648.02M | $222.36M | $160.50M | - | - | - |